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Abstract
A series of 1,4-dihydropyridines have been prepared from a three-component 
one-pot condensation reaction of β-diketonates, an aromatic aldehyde, and ammo-
nium acetate under microwave irradiation. The reaction is performed using crystal-
line nano-ZnO in ethanol under microwave irradiation (CEM discover). A wide 
range of functional groups was tolerated in the developed protocol. The present 
methodology offers several advantages such as simple procedure, greener condi-
tion, excellent yields and short reaction time. The synthesized compounds were 
evaluated for DNA photocleavage, SAR analysis and molecular docking studies. 
The compound (4b, 4c, 4 h, 4i, 4n and 4o) showed potent DNA cleavage activities 
compared to other derivatives. The molecular interactions of the active compounds 
within the binding site of B-DNA were studied through molecular docking simula-
tions; the compound (4b, 4c, 4 h, 4i, 4n and 4o) showed good docking interaction 
with minimum binding energies. All synthetic compounds were characterized by 
different spectroscopic techniques.
Keywords: 1,4-Dihydropyridines, DNA photocleavage, molecular docking, SAR 
analysis, ZnO nanoparticle
1. Introduction
Facile and efficient synthesis of biological active molecules is one of the main 
objectives of organic and medicinal chemistry. In recent years, multicomponent 
reactions have become one of the important tools in the synthesis of structurally 
diverse chemical libraries of drug-like polyfunctional organic molecules [1–4]. 
Furthermore, MCRs offer the advantage of simplicity and synthetic efficiency over 
conventional chemical reactions in several aspects. MCRs allow the construction of 
combinatorial libraries of complex organic molecules for an efficient lead structure 
identification and optimization in drug discovery [5–10].
In continuation of our ongoing research work on microwave assisted synthesis 
of nano materials [11, 12] we have found that, nano-crystalline metal oxides have 
attracted considerable attention of synthetic and medicinal chemists because of 
their high catalytic activity and reusability [13–25]. Zinc oxide is an inexpensive, 
moisture stable, reusable, commercially available and is non-toxic, insoluble in 
polar as well as non-polar solvents [26–31]. A wide range of organic reactions 
that include Beckmann rearrangements [32], N-benzylation [33], acylation [34], 
dehydration of oximes [35], nucleophilic ring opening reactions of epoxides [36], 
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synthesis of cyclic urea [37], N-formylation of amines [38]. In particular crystal-
line nano-ZnO oxide exhibit better catalytic activity compared to their bulk sized 
counterparts [29, 39–42].
In recent years, much attention has been directed toward the synthesis of dihy-
dropyridine compounds owing to their tremendous application in various research 
fields including biological science and medicinal chemistry [43, 44]. Many DHPs 
are already commercial products such as: amlodipine, felodipine, isradipine, laci-
dipine, nicardipine, nitrendipine, nifedipine and nimodipine B, of which nitren-
dipine and nemadipine B exhibit potent calcium channel blocking activities [45–49] 
(Figure 1) and have emerged as one of the most important classes of drugs for the 
treatment of cardiovascular diseases [50, 51]. Moreover dihydropyridine deriva-
tives possess a variety of biological activities like, geroprotective, hepatoprotective, 
anti-atherosclerotic, antitumor, and antidiabetic activities [46, 52, 53]. Widespread 
studies have uncovered that dihydropyridine unit containing compounds exhibit 
various medicinal functions such as neuroprotectant, platelet anti-aggregatory 
activity, cerebral anti ischemic activity in the treatment of Alzheimer’s disease, 
chemosensitizer in tumor therapy [54–56]. Drug-resistance modifiers [57], antioxi-
dants [58] and a drug for the treatment of urinary urge incontinence [59].
In order to model and understand these biological properties and to develop 
new chemotherapeutic agents based upon the 1,4-DHP compounds, significant 
effort has been devoted to establish effective methods for their synthesis. Generally, 
1,4-DHPs were synthesized by Hantzsch method [60], which involves cyclocon-
densation of an aldehyde, a β-ketoester and ammonia either in acetic acid or under 
reflux in alcohols for long reaction times which typically leads to low yields [46, 61, 
62]. Other methods comprise the use of microwaves [63–65], high temperatures at 
reflux [66–69], organocatalysts [70] and metal triflates [71].
Recently, DNA is an important drug target and it regulates many biochemical 
processes that occur in the cellular system. Small-molecule interactions with DNA 
continue to be intensely and widely studied for their usefulness as probes of cellular 
replication and transcriptional regulation and for their potential as pharmaceuticals 
[72–75]. In particular, designing of the compound based on their ability to cleave 
DNA is of great importance not only from the primary biological point of view 
Figure 1. 
Drugs containing 1,4-DHP moieties.
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but also in terms of photodynamic therapeutic approach to develop potent drugs 
[72–75]. 1,4-Dihydropyridine derivatives have attracted the attention of the chem-
ists because of their diverse biological applications [76]. The biological significance 
of this class of compounds impelled us to extend this series by working on the 
synthesis and DNA photocleavage studies of 1,4-dihydropyridine derivatives. In 
this communication, synthesis of 1,4-dihydropyridine derivatives and their DNA 
photocleavage studies and molecular docking have been reported.
In literature, there are several methods known for the synthesis of 1,4-dihy-
dropyridine derivatives. In continuation of our program on the chemistry of nano 
material, herein we report an efficient microwave method for the synthesis of 
crystalline ZnO-NPs. The ZnO used in this work was synthesized according to a 
modified method. The prepared crystalline ZnO-nano-particle was characterized 
using powder XRD, SEM, EDX (Figure 2). Our synthetic approach started with the 
condensation of 1 equiv. of benzaldehyde 1a with 2 equiv. of ethyl acetoacetate 2a 
and 2 equiv. of NH4OAc 3a in the presence of ZnO-Nps resulted in the formation of 
Hantzsch 1,4-dihydropyridine 4a (Figure 3). The reaction was complete in 5 min 
under microwave irradiation and the product was isolated by the usual work-up, in 
90% yield and high purity. Under similar conditions, various substituted aromatic 
aldehydes carrying either electron-donating or -withdrawing substituents reacted 
with 1,3-diketones to form 1,4-DHPs in good to excellent yields, and the results are 
summarized in Table 1.
A microwave irradiation-assisted process very often minimizes the formation 
of byproducts and requires much less time than thermal methods. The main ben-
efits of performing reactions under controlled conditions in sealed vessels are the 
significant rate enhancements and the higher product yields that can frequently 
be achieved. Therefore, in continuation of our studies on microwave synthesis 
of nano-materials [77–81], we have attempted to develop a rapid, microwave-
assisted protocol for the synthesis of 1,4-DHPs using crystalline ZnO-nano 
catalyst (Figure 3).
The DNA cleavage of 1,4-DHP derivatives were studied by agarose gel electro-
phoresis. When circular plasmid DNA was subjected to electrophoresis, relatively 
fast migration was observed for the intact supercoiled DNA (type I). If scission 
occurs on one strand (nicking), the supercoiled DNA will relax to generate a slower 
moving open circular form (type II). If both strands are cleaved, a linear form 
Figure 2. 
(a) Powder XRD of obtained ZnO nano particles by microwave method; (b) SEM images of ZnO-NPs;  
(c) EDX analysis spectrum of obtained ZnO nano particles by microwave method.
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(type III) that migrates between type I and type II will be generated [82–85]. The 
conversion of type I (supercoiled) to type II (nicked circular) was observed with 
different concentration of 1,4-DHP and irradiated for 2 h, in 1:9 DMSO/trisbuffer 
(20 μM, pH- 7.2) at 365 nm. No DNA cleavage was observed for the control in which 
1,4-DHP was absent (lane 1) (Figure 4). With increasing concentration of these 
1,4-DHP the amount of type I of pUC 19 DNA diminished gradually, whereas type 
II increased (Figure 4).
At 40 μM concentration, the Compound (4c) can promote only 30% conversion 
of DNA from type I to II (Figure 5). At the concentration of 80 μM, compound (4c) 
Figure 3. 
Synthesis of 1,4-dihydropyridines.
Entrya R R1 Products Entrya Yield (%)b
1 C6H5 t-Bu 4a 1 90
2 4-MeO-C6H5 t-Bu 4b 2 95
3 4-OH-C6H5 t-Bu 4c 3 95
4 4-F-C6H5 t-Bu 4d 4 95
5 4-Cl-C6H5 t-Bu 4e 5 90
6 4-NO2-C6H5 t-Bu 4f 6 95
7 C6H5 Et 4 g 7 90
8 4-MeO-C6H5 Et 4 h 8 95
9 4-OH-C6H5 Et 4i 9 92
10 4-F-C6H5 Et 4j 10 92
11 4-Cl-C6H5 Et 4 k 11 90
12 4-NO2-C6H5 Et 4 l 12 90
13 C6H5 Me 4 m 13 90
14 4-MeO-C6H5 Me 4n 14 87
15 4-OH-C6H5 Me 4o 15 90
16 4-F-C6H5 Me 4p 16 90
17 4-Cl-C6H5 Me 4q 17 90
18 4-NO2-C6H5 Me 4r 18 90
aAll the products were characterized by 1H NMR and 13C NMR studies and compared with the literature mps. 
bYields of isolated products
Table 1. 
Synthesis of 1,4-dihydropyridines.
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can almost promote the about 80% conversion of DNA from type I to II (Figure 5). 
The cleavage potential of the test compounds were assessed by comparing the bands 
appeared in control and test compounds at 80 μM concentration. However, other 
derivatives exhibits much lower cleaving efficiency for pUC 19 DNA. Even at the 
concentration of 80 μM, it can promote only 40% conversion of DNA from type I to 
II (Figure 5).
But at higher concentrations around 130 μM, the compounds get precipitated 
and there is no moment in the DNA. The image (Figure 6) clearly demonstrates 
that compounds (4b, 4c, 4d, 4e, 4f and 4 g) shows DNA cleavage of pUC19 DNA 
at 80 μM concentration. The results indicated that compounds bearing –OCH3 and 
–OH at -para position of phenyl ring (C-6) did cleave the DNA completely, other 
compounds have displayed nearly complete cleavage of DNA. Overall, it indicates 
that, the alkoxy groups are highly reactive radicals, which abstracts hydrogen atoms 
efficiently at C-4′ of 2-deoxyribose. It is of interest to note that hydroxyl group has 
been reported to bring about oxygen radical mediated DNA damage in the presence 
of photoirradiation [86].
The structure–activity relationship studies of 1,4-DHPs with regard to DNA 
photocleavage studies shows that, the changes in the substitution pattern at C-3, 
C-4, and C-5 positions alter the 1,4-DHP ring. Osiris Property Explorer is one such 
knowledge based activity prediction tool which predicts drug likeliness, drug score 
and undesired properties such as mutagenic, tumorigenic, irritant and reproductive 
effect of novel compounds based on chemical fragment data of available drugs and 
non-drugs as reported (Table 2) [87]. It was observed that, the compounds having 
aliphatic groups such as –CH3, –COOCH3, –COOC2H5 and –COOC(CH3)3, attached 
to C-2 and C-3 of 1,4-DHP exhibited good activity. Other derivatives possessing, 
an electron-donating substituent, such as hydroxy and methoxy group on the 
phenyl ring (C-6) increases DNA photocleavage activity. A lone pair of electrons 
on oxygen atom of methoxy group delocalizes into the π space of benzene ring, 
Figure 4. 
Light-induced DNA cleavage by 1,4-DHP. The 1,4-DHP was irradiated with UV light at 365 nm. Lane; 1: 
Control DNA (with out compound), lane; 2: 20 μM (4c), lane; 3: 40 μM (4c), lane; 4: 60 μM (4c), lane; 5: 
80 μM (4c).
Figure 5. 
Light-induced DNA cleavage by 1,4-DHP. The 1,4-DHP was irradiated with UV light at 365 nm. Lane; 1: 
Control DNA (with out compound), lane; 2: 40 μM (4a), lane; 3: 40 μM (4b), lane; 4: 40 μM (4c), lane; 5: 
40 μM (4d), lane; 5: 40 μM (4e), lane; 5: 40 μM (4f), lane; 5: 40 μM (4 g).
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thereby increasing the activity. Similarly, electron-withdrawing substituent’s, such 
as 4-fluorophenyl, 4-chloro phenyl of 1,4-DHP lower the activity. These results 
indicate that, the alkoxy substituent’s and nitrogen of pyridine ring in the 1,4-DHP 
structure are the responsible for DNA cleavage.
In order to rationalize the observed spectroscopic results and to get more insight 
into the intercalation modality, the 1,4-DHP (4a–r) were successively docked 
[88–90] within the DNA duplex of sequence d(CGCGAATTCGCG)2 dodecamer 
Figure 6. 
Light-induced DNA cleavage by 1,4-DHP. The 1,4-DHP was irradiated with UV light at 365 nm. Lane; 1: 
Control DNA (with out compound), lane; 2: 80 μM (4a), lane; 3: 80 μM (4b), lane; 4: 80 μM (4c), lane; 5: 
80 μM (4d), lane; 5: 80 μM (4e), lane; 5: 80 μM (4f), lane; 5: 80 μM (4 g).





Mb Tc Id Re
4a 329 3.29 2.41 0.77 (+) (+) (+) (+)
4b 359 3.22 2.34 0.75 (+) (+) (+) (+)
4c 345 2.94 2.48 0.79 (+) (+) (+) (+)
4d 347 3.39 1.65 0.70 (+) (+) (+) (+)
4e 419 5.37 −17.92 0.22 (+) (+) (+) (+)
4f 430 4.17 −19.36 0.10 (−) (+) (+) (−)
4 g 301 2.48 4.04 0.87 (+) (+) (+) (+)
4 h 331 2.41 3.87 0.51 (+) (+) (+) (+)
4i 317 2.13 4.08 0.53 (+) (+) (+) (+)
4j 319 2.58 3.29 0.50 (+) (+) (+) (+)
4 k 363 3.89 3.33 0.68 (+) (+) (+) (+)
4 l 374 2.69 1.92 0.25 (−) (+) (+) (−)
4 m 269 2.98 4.09 0.50 (+) (+) (+) (+)
4n 299 2.91 3.94 0.49 (+) (+) (+) (−)
4o 285 2.63 4.14 0.51 (+) (+) (+) (+)
4p 287 3.08 3.42 0.47 (+) (+) (+) (−)
4q 335 3.08 4.97 0.48 (+) (+) (+) (−)
4r 346 1.88 3.50 0.30 (−) (+) (+) (−)
aRanking as (+) no bad effect, (+/−) medium bad effect, (−) bad effect. 
bM (mutagenic effect); 
cT (tumorigenic effect); 
dI (irritant effect);  
eR (reproductive effect).
Table 2. 
Drug likeliness properties of 1,4-dihydro pyridines according to Osiris property explorer tool.
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(PDB ID: 1BNA) in order to predict the chosen binding site along with preferred 
orientation of the ligand inside the DNA minor groove. All synthesized 1,4-DHP 
derivatives were drawn in ChemSketch and structures were saved in .mol format. 
Afterwards the .mol format was used in Hyperchem-7, to adjust their fragments, 
followed by total energy minimization of ligands so that they can attain a stable 
conformation and the file was saved in .pdb format.
Protein 3D structure of B-DNA was obtained from RCSB PDB (an information 
portal to biological macromolecular structures). The water molecules were removed 
from the file, and the protein was protonated in 3D to add polar hydrogen’s. Binding 
pocket was identified using site finder, and the respective residues were selected. 
Docking parameters were set to default values and scoring algorithm, the docking 
runs were retained to 30 conformations per ligand. The docked protein structures 
were saved in .pdb format, and ligand’s conformations were investigated one by 
one. Complexes with best conformations were selected on the basis of highest score, 
lowest binding energy and minimum RMSD values [91].
The synthesized organic compounds perform their biological activity more effi-
ciently by binding respective protein or DNA at their specific binding site. Identification 
of interacting residues with ligands is a necessary step toward rational drug designing, 
understanding of molecular pathway and mechanistic action of protein.
Molecular docking was carried out between rigid receptor protein and the flex-
ible ligands. Table 3 shows the details of the docking results including RMSD and 
binding energy values of protein–ligand complexes. The ligands (4b, 4c, 4 h, 4i, 
4n and 4o) bind strongly to B-DNA as inferred by their minimum binding energy 
values, that is, −13.8, −12.9 and − 12.3 kcal/mol, respectively (Figure 7).
Figure 8 shows the position of active site in the helical structure of DNA and it 
also shows that all docked ligands clustered inside the pocket. Figure 8 exhibited 
Products Docking energy (Kcal/mol) Inhibition constant (M) RMSD
4a −6.23 4.35 × 10−7 2.5
4b −24.12 1.81 × 10−16 1.1
4c −21.74 1.96 × 10−16 1.5
4d −5.72 5.96 × 10−7 3.4
4e −7.24 6.31 × 10−7 3.4
4f −6.85 4.88 × 10−7 3.8
4 g −7.41 4.51 × 10−7 2.0
4 h −22.35 1.92 × 10−16 1.0
4i −19.81 2.32 × 10−16 1.0
4j −6.34 5.88 × 10−7 2.1
4 k −6.68 6.76 × 10−7 2.1
4 l −8.22 5.18 × 10−7 2.4
4 m −7.55 4.68 × 10−7 2.3
4n −22.64 1.96 × 10−16 1.1
4o −20.36 2.18 × 10−16 1.0
4p −6.78 6.20 × 10−7 1.5
4q −6.52 7.15 × 10−7 1.8
4r −7.89 6.32 × 10−7 1.5
Table 3. 
Molecular docking studies of 1,4-dihydropyridines.
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the hydrogen bond interaction of 4c and 4d with key residues in active site inside 
the helical structure of DNA. In this model, it is clearly indicated that the com-
pound 4c formed hydrogen bonded between the –OH and N1 of thymine, which is 
DT7 and DT19 with the bond length of 2.02 and 2.05 Ǻ respectively. Moreover, the 
other derivatives of 1,4-DHP formed less H-bond interaction with the DNA due to 
the orientation of aromatic ring involved in van der Waals interactions (Wireframe 
model) and flat hydrophobic regions of the binding sites of DNA (Table 3). These 
results demonstrated the in silico molecular docking studies of 1,4-DHPs with 
B-DNA suggested that 1,4-DHPs possess the potential to disturb hydrophobic and 
H-bond interactions thereby affecting the stability of attachment of B-DNA, and 
may be effective for cancer cell lines.
Figure 7. 
1,4-DHP was successively docked within the DNA duplex of sequence d(CGCGAATTCGCG)2 dodecamer 
(PDB ID: 1BNA).
Figure 8. 
Interaction of 1,4-DHP with DNA duplex of sequence d(CGCGAATTCGCG)2 dodecamer (PDB ID: 1BNA).
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2. Experimental
2.1 Materials and method
All the chemicals used in the present study are of AR grade. Whenever analyti-
cal grade chemicals were not available, laboratory grade chemicals were purified 
and used. AlCl3, ZnCl2, Yb(OTF)3, FeCl3 and Zinc acetate obtained from Merck 
chemicals and are directly used without further purification. Melting points were 
recorded on an open capillary tube with a Buchi melting point apparatus and are 
uncorrected. 1H- NMR spectra were obtained using a 400 MHz on a Bruker spec-
trometer (chemical shifts in δ ppm).
2.1.1 General procedure for the preparation of ZnO-Nps
In a typical synthesis process, zinc acetate dihydrate (1.1 g, 0.01 M) was dis-
solved in 20 mL of ethanol with constant stirring for 20 min. Then KOH (0.178 M) 
was added into the above mixed solution. After further stirring for 5 min, the reac-
tion mixture was put into a CEM microwave synthesizer to irradiate for 10 min with 
the power set at 150 W, Temperature at 150°C and Pressure 150 C0. After comple-
tion of reaction, the white precipitate was collected by centrifugation, washed twice 
with deionized water, ethanol and dried in vacuum oven at 60°C for 5 h.
Crystalline structure of the prepared ZnO-Nps was determined by powder X-ray 
diffraction (XRD). The strong intensity and narrow width of diffraction peaks 
indicate the high crystallinity of the prepared ZnO-Nps (Figure 2a). The peaks are 
indexed as 31.82° (100), 34.54° (002), 36.42° (101), 47.46° (102), 56.74° (110), 62.92° 
(103), 66.06° (200), 68.42° (112), 69.06° (201) and 78.82° (202) respectively. This 
revealed that the resultant nanoparticles were pure ZnO with a hexagonal structure 
(JCPDS 36-1451). No impurities could be detected in this pattern, which implies 
hexagonal phase ZnO nanoparticles could be obtained under the current microwave 
method. X-ray diffraction shows that metal oxide is pure ZnO having hexagonal 
structure. Sharpness of the peaks shows good crystal growth of the oxide particles. 
Average particle sizes of the ZnO have been calculated using from high intensity 
peak using Image J.
2.1.2 General procedure for the synthesis of 1,4-DHP by microwave method
A mixture of aromatic aldehydes 1a (5 mmol), ethyl acetoacetate 2 (10 mmol), 
and ammonium acetate 3 (10 mmol) and ZnO (10 mol %) was taken in ethanol 
(20 mL) and the mixture was heated at microwave irradiation for 5 min (monitored 
by TLC after 5 min. interval). After 5 min, the reaction mixture was cooled to room 
temperature and then it was poured into cold water. The product was extracted 
with ethyl acetate. The organic layer was washed with brine, water and dried over 
anhydrous Na2SO4. The crude product thus obtained was recrystallized from EtOH 
to obtain desired product (Figure 3, Table 1).
4a.  Di-tert-Butyl − 1,4-dihydro-2,6-dimethyl-4-phenylpyridine-3,5- 
dicarboxylate
Solid: MP 180–182°C; 1H NMR (500 MHz, CDCl3) δ 1.43 (s, 18H), 2.30 (s, 6H), 
4.83 (s, 1H), 5.58 (brs, 1H), 7.05-7.10 (m, 1H), 7.10-7.20 (m, 2H), 7.23-7.30 (m, 2H); 
13C NMR (125 MHz, CDCl3) δ 20.0, 28.4, 40.0, 80.0, 105.5, 125.6, 127.5, 128.5, 129.2, 
143.0, 147.5, 167.3.
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4b.  Di-tert-butyl 4-(4-methoxyphenyl)-l,4-dihydro-2,6-dimethylpyridine-
3,5-dicarboxylate
Solid: MP 168–170°C; 1H NMR (500 MHz, CDCl3) δ 1.40 (s, 18H), 2.25 (s, 6H), 
3.86 (s, 3H), 4.81 (s, 1H), 5.51 (brs, 1H), 7.10-7.20 (d, 2H), 7.40-7.50 (d, 2H); 13C 
NMR (125 MHz, CDCl3) δ 19.8, 30.0, 41.0, 56.0, 81.0, 106.1, 125.6, 127.8, 135.0, 
146.4, 153.2, 160.0, 167.5.
4c.  Di-tert-butyl 4-(4-hydroxy-phenyl)-l,4-dihydro-2,6-dimethylpyridine-
3,5-dicarboxylate
Solid: MP 230–232°C; 1H NMR (500 MHz, CDCl3) δ 1.36 (s, 18H), 2.28 (s, 6H), 
4.90 (s, 1H), 5.56 (brs, 1H), 6.86-6.90 (d, 2H), 7.10-7.20 (d, 2H), 10.10 (s, 1H); 13C 
NMR (125 MHz, CDCl3) δ 24.5, 32.8, 45.3, 88.0, 108.4, 128.3, 131.0, 134.2, 134.6, 
136.8, 148.4, 154.6, 172.6.
4d.  Di-tert-butyl − 4-(4-fluorophenyl)-l,4-dihydro-2,6-dimethylpyridine-
3,5-dicarboxylate
Solid: MP 150–152°C; 1H NMR (500 MHz, CDCl3) δ 1.43 (s, 18H), 2.30 (s, 
6H), 4.81 (s, 1H), 5.50 (brs, 1H), 6.90-6.96 (d, 2H), 7.15-7.20 (d, 2H); 13C NMR 
(125 MHz, CDCl3) δ 20.0, 21.3, 38.9, 40.0, 79.8, 106.0, 114.2, 113.7, 125.4, 126.8, 
129.2, 142.5, 143.2, 160.0, 162.5, 167.1.
4e.  Di-tert-butyl 4-(4-chlorophenyl)-l,4-dihydro-2,6-dimethylpyridine-
3,5-dicarboxylate
Solid: MP 188–190°C; 1U NMR (500 MHz, CDCl3) δ 1.38 (s, 18H), 2.25 (s, 6H), 
4.85 (s, 1H), 5.50 (brs, 1H), 6.80-6.85 (d, 2H), 7.00-7.08 (d, 2H); 13C NMR (125 MHz, 
CDCl3) δ 24.3, 33.4, 45.1, 86.2, 108.8, 128.9, 130.4, 133.5, 134.3, 136.1, 148.6, 151.6, 172.4.
4 f.  Di-tert-butyl − 4-(4-nitrophenyl)-l,4-dihydro-2,6-dimethylpyridine-
3,5-dicarboxylate
Solid: MP 176–178°C; 1H NMR (500 MHz, CDCl3) δ 1.38 (s, 18H), 2.30 (s, 6H), 
4.86 (s, 1H), 5.55 (brs, 1H), 7.00–7.10 (d, 2H), 7.15–7.25 (d, 2H); 13C NMR (125 
MHz, CDCl3) δ 20.5, 22.4, 38.6, 40.1, 79.6, 107.0, 114.5, 114.6, 126.2, 126.8, 129.6, 
142.6, 144.6, 161.0, 167.1.
4 g.  2,6-Dimethyl-4-phenyl-1,4-dihydro-pyridine-3,5-dicarboxylic acid  
diethyl ester
Solid: MP 158–160°C; 1H NMR (CDCl3, 400 MHz): δ 1.20 (t, J = 9.7 Hz, 6H, 
2CH3CH2), 2.28 (s, 6H, 2CH3), 4.10 (q, J = 6 Hz, 4H, 2CH3CH2), 5.00 (s, 1H, 
CH), 5.75 (s, 1H, NH), 7.10–7.50 (m, 5H); 13C NMR (CDCl3, 75 MHz): δ = 14.20 
(C-3″), 19.5 (C-1″), 39.6 (C-4), 59.5 (C-2″), 104.1 (C-3 and C-5), 126.0 (C-4′),  
127.8 (C-3′ and C-5′), 130.0 (C-2′ and C-6′), 143.8 (C-2 and C-6), 148.0 (C-1′), 
168.0 (C-4″).
4 h.  2,6-Dimethyl-4-(4-methoxy-phenyl)-1,4-dihydro-pyridine-3,5-
dicarboxylic acid diethyl ester
Solid: MP 160–162°C; 1H NMR (CDCl3, 400 MHz): δ 1.21 (t, J = 7.0 Hz, 6H), 
2.30 (s, 6H), 3.78 (s, 3H), 4.10 (q, J = 6.3 Hz, 4H), 4.95 (s, 1H), 5.60 (s, 1H), 6.80 
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(d, J = 8.4 Hz, 2H), 7.18 (d, J = 8.7 Hz, 2H); 13C NMR (CDCl3, 75 MHz): δ 14.2, 19.6, 
38.8, 55.2, 59.8, 104.0, 115.0, 128.8, 140.0, 145.3, 156.7, 168.0.
4i.  2,6-Dimethyl-4-(4-hydroxy-phenyl)-1,4-dihydro-pyridine-3,5-dicarboxylic 
acid diethyl ester
Solid: MP 238–240°C; 1H NMR (CDCl3, 400 MHz): δ 1.18 (t, J = 7.2 Hz, 6H), 2.28 
(s, 6H), 4.05 (q, J = 6.6 Hz, 4H), 4.90 (s, 1H), 5.61 (s, 1H), 6.70 (d, J = 8.7 Hz, 2H), 
7.15 (d, J = 8.4 Hz, 2H), 9.90 (s, 1H); 13C NMR (CDCl3, 75 MHz): δ 14.0, 18.9, 39.0, 
59.0, 103.0, 114.2, 128.3, 139.4, 144.2, 154.1, 167.6.
4j.  2,6-Dimethyl-4-(4-fluoro-phenyl)-1,4-dihydro-pyridine-3,5-dicarboxylic 
acid diethyl ester
Solid: MP 152–154°C; 1H NMR (CDCl3, 400 MHz): δ 1.10 (t, J = 7.2 Hz, 6H), 2.25 
(s. 6H), 4.00 (q, J = 5.7 Hz, 4H), 4.88 (s, 1H), 5.68 (s, 1H), 6.80 (m, 2H), 7.15(m, 
2H); 13C NMR (CDCl3, 75 MHz): δ 14.3, 19.7, 39.6, 60.1, 104.2, 114.4, 129.4, 129.7, 
130.0, 143.5, 147.0, 167.5.
4 k.  2,6-Dimethyl-4-(4-chloro-phenyl)-1,4-dihydro-pyridine-3,5-dicarboxylic 
acid diethyl ester
Solid: MP 153–155°C; 1H NMR (CDCl3, 400 MHz): δ 1.12 (t, J = 7.2 Hz, 6H), 2.35 
(s. 6H), 4.12 (q, J = 5.7 Hz, 4H), 5.10 (s, 1H), 5.82 (s, 1H), 7.50 (d, 2H), 8.16 (d, 2H); 
13C NMR (CDCl3, 75 MHz): δ 14.2, 18.6, 39.6, 60.0, 101.6, 116.8, 127.8, 129.3, 130.2, 
144.8, 147.2, 166.8.
4 l.  2,6-Dimethyl-4-(4-nitro-phenyl)-1,4-dihydro-pyridine-3,5-dicarboxylic 
acid diethyl ester
Solid: MP 178–180°C; 1H NMR (CDCl3, 400 MHz): δ 1.26 (t, J = 7.2 Hz, 6H), 2.35 
(s. 6H), 4.06 (q, J = 5.7 Hz, 4H), 5.08 (s, 1H), 5.76 (s, 1H), 7.48 (m, 2H), 8.02 (m, 
2H); 13C NMR (CDCl3, 75 MHz): δ 14.2, 19.5, 39.6, 59.6, 104.2, 121.3, 1234.0, 128.4, 
136.8, 144.5, 147.8, 148.8, 167.5.
4 m.  2,6-Dimethyl-4-phenyl-1,4-dihydro-pyridine-3,5-dicarboxylic acid 
dimethyl ester
Solid: MP 194–196°C; 1H NMR (CDCl3, 400 MHz): δ 2.30 (s, 6H, 2CH3), 3.66 
(s, 6H, 2CH3), 5.00 (s, 1H, CH), 5.80 (b, 1H), 7.20-7.56 (m, 5H); 
13C NMR (CDCl3, 
75 MHz): δ = 19.7, 38.7, 50.5, 105.5, 126.2, 127.0, 128.0, 144.1, 147.1, 168.2.
4n.  2,6-Dimethyl-4-(4-methoxy-phenyl)-1,4-dihydro-pyridine-3,5-
dicarboxylic acid dimethyl ester
Solid: MP 185–187°C; 1H NMR (CDCl3, 400 MHz): δ 2.28 (s, 6H, 2CH3), 3.60 (s, 
6H, 2CH3), 3.78 (s, 3H), 4.89 (s, 1H, CH), 5.30 (b, 1H), 6.80–7.10 (m, 4H); 
13C NMR 
(CDCl3, 75 MHz): δ 19.5, 38.7, 55.1, 51.8, 104.4, 113.2, 128.9, 140.4, 143.4, 158.0, 167.7.
4o.  2,6-Dimethyl-4-(4-hydroxy-phenyl)-1,4-dihydro-pyridine-3,5-dicarboxylic 
acid dimethyl ester
Solid: MP 228–230°C; 1H NMR (CDCl3, 400 MHz): δ 2.26 (s, 6H, 2CH3), 3.63 
(s, 6H, 2CH3), 5.00 (s, 1H, CH), 5.40 (b, 1H), 6.95–7.20 (m, 4H); 
13C NMR (CDCl3, 
75 MHz): δ 18.4, 38.4, 51.8, 103.1, 114.2, 128.4, 139.0, 144.2, 155.0, 167.6.
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4p.  2,6-Dimethyl-4-(4-fluoro-phenyl)-1,4-dihydro-pyridine-3,5-dicarboxylic 
acid dimethyl ester.
Solid: MP 170–172°C; 1H NMR (CDCl3, 400 MHz): δ 2.32 (s, 6H, 2CH3), 3.64 (s, 
6H, 2CH3), 4.98 (s, 1H, CH), 5.78 (b, 1H), 7.10 (t, 2H), 7.32 (t, 2H); 
13C NMR (CDCl3, 
75 MHz): δ 19.5, 40.0, 51.0, 104.1, 114.4, 129.3, 130.0, 144.1, 145.3, 160.5, 162.3, 167.6.
4q.  2,6-Dimethyl-4-(4-chloro-phenyl)-1,4-dihydro-pyridine-3,5-dicarboxylic 
acid dimethyl ester
Solid: MP 194–196°C; 1H NMR (CDCl3, 400 MHz): δ 2.30 (s, 6H, 2CH3), 3.66 
(s, 6H, 2CH3), 4.95 (s, 1H, CH), 5.76 (b, 1H), 7.15 (m, 2H), 7.36 (m, 2H); 
13C NMR 
(CDCl3, 75 MHz): δ 19.5, 39.6, 51.1, 103.6, 113.8, 128.2, 130.0, 144.4, 146.2, 160.4, 167.8.
4r.  2,6-Dimethyl-4-(4-nitro-phenyl)-1,4-dihydro-pyridine-3,5-dicarboxylic 
acid dimethyl ester
Solid: MP 210–212°C; 1H NMR (CDCl3, 400 MHz): δ 3.00 (s, 6H, 2CH3), 3.61 
(s, 6H, 2CH3), 5.08 (s, 1H, CH), 5.86 (b, 1H), 7.30 (m, 2H), 7.62 (m, 2H); 
13C NMR 
(CDCl3, 75 MHz): δ 19.7, 40.1, 51.2, 103.2, 114.4, 128.7, 145.0, 146.1, 156.2, 167.6.
3. Conclusion
In conclusion, the present study describes the ZnO-NPs catalyzed synthesis of 
1,4-dihydropyridines (4a–r) under microwave irradiation, giving excellent yields 
in shorter reaction time as compared to conventional method. All the synthesized 
compounds were evaluated for DNA photocleavage, SAR and DNA docking studies. 
DNA cleavage by gel electrophoresis method revealed that compounds (4b and 4c) 
were found to cleave the DNA completely. The preliminary SAR study revealed that 
the –OCH3 and –OH substituted compounds, were more favorable for activity, par-
ticularly at -para position of the phenyl ring. Docking studies indicated that one of 
the ester moieties of these compounds played a key role in their interactions with the 
DNA. However, the nature of reactive intermediates involved in the DNA cleavage by 
the 1,4-dihydropyridines has not been clear. Needless to say, further understanding 
the mechanism of biological action are still required in order to fully develop these 
compounds as potent anticancer drugs.
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